TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 23 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26,279,495 | -20.4% | 40,689,000 | 0.0% | 0.03% | -20.6% |
Q2 2023 | $33,015,536 | -12.0% | 40,689,000 | +6.5% | 0.03% | -15.0% |
Q1 2023 | $37,523,700 | +8.0% | 38,189,000 | 0.0% | 0.04% | +5.3% |
Q4 2022 | $34,756,223 | +17.5% | 38,189,000 | +31.7% | 0.04% | +8.6% |
Q3 2022 | $29,571,000 | +1.6% | 29,000,000 | 0.0% | 0.04% | +2.9% |
Q2 2022 | $29,118,000 | -2.5% | 29,000,000 | +3.6% | 0.03% | +21.4% |
Q1 2022 | $29,869,000 | – | 28,000,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Context Capital Management, LLC | 18,167 | $17,858 | 1.50% |
BRAIDWELL LP | 28,350,000 | $27,868,050 | 0.92% |
READYSTATE ASSET MANAGEMENT LP | 9,000,000 | $8,847,000 | 0.82% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,382,000 | $20,985 | 0.77% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 20,000,000 | $19,700,500 | 0.60% |
CSS LLC/IL | 8,178,000 | $8,038,680 | 0.53% |
WOLVERINE ASSET MANAGEMENT LLC | 37,900,000 | $37,317,810 | 0.44% |
Segantii Capital Management Ltd | 10,000,000 | $9,827,050 | 0.34% |
LINDEN ADVISORS LP | 28,993,000 | $28,511,354 | 0.30% |
CAPSTONE INVESTMENT ADVISORS, LLC | 30,893,000 | $30,367,819 | 0.15% |